These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11865774)

  • 1. [Suspected neurological side-effects of tick-borne meningoencephalitis vaccination: experiences of the Swiss Adverse Drug Reaction Reporting Center].
    Doser AK; Hartmann K; Fleisch F; Kuhn M
    Praxis (Bern 1994); 2002 Jan; 91(5):159-62. PubMed ID: 11865774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurological side effects following vaccination of early-summer meningoencephalitis. Case report and experiences of the Swiss Center for Adverse Drug Effects].
    Goerre S; Kesselring J; Hartmann K; Kuhn M; Reinhart WH
    Schweiz Med Wochenschr; 1993 Apr; 123(14):654-7. PubMed ID: 8480164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.
    Beran J; Douda P; Gniel D; Zent O
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():130-3. PubMed ID: 15146994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
    Schöndorf I; Beran J; Cizkova D; Lesna V; Banzhoff A; Zent O
    Vaccine; 2007 Feb; 25(8):1470-5. PubMed ID: 17196713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Active vaccination against early summer meningoencephalitis].
    Müller A
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1110-6. PubMed ID: 9691346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of tick-borne encephalitis (TBE)].
    Aebi C
    Ther Umsch; 2005 Nov; 62(11):726-30. PubMed ID: 16350534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunization against tick-borne encephalitis].
    Krause M; Majer S
    Ther Umsch; 2016; 73(5):253-6. PubMed ID: 27268448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the efficiency of tick-borne encephalitis vaccination in the population in the natural foci of Austria].
    Heinz F; Holtzmann H; Essl A; Kundt M
    Vopr Virusol; 2008; 53(2):19-27. PubMed ID: 18450105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
    Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
    Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
    Zent O; Schwarz TF; Plentz A; Banzhoff A; Jilg W
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():134-8. PubMed ID: 15146995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in vaccination against tick-borne encephalitis.
    Rendi-Wagner P
    Expert Rev Vaccines; 2008 Jul; 7(5):589-96. PubMed ID: 18564014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High burden of tick-borne encephalitis in Slovenia--challenge for vaccination policy.
    Grgič-Vitek M; Klavs I
    Vaccine; 2011 Jul; 29(32):5178-83. PubMed ID: 21620916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
    Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early summer meningoencephalitis vaccination, a preventive medicine measure with high acceptance in Austria].
    Kunz C; Hofmann H; Dippe H
    Wien Med Wochenschr; 1991; 141(12):273-6. PubMed ID: 1949821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to tick-borne encephalitis vaccine: FSME-Immun.
    Grzeszczuk A; Sokolewicz-Bobrowska E; Prokopowicz D
    Infection; 1998; 26(6):385-8. PubMed ID: 9861565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined cross-sectional analysis and case-control study evaluating tick-borne encephalitis vaccination coverage, disease and vaccine effectiveness in children and adolescents, Switzerland, 2005 to 2022.
    Zens KD; Altpeter E; Wymann MN; Mack A; Baer NB; Haile SR; Steffen R; Fehr JS; Lang P
    Euro Surveill; 2024 May; 29(18):. PubMed ID: 38699900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule.
    Zent O; Jilg W; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Banzhoff A
    Vaccine; 2003 Dec; 21(32):4655-60. PubMed ID: 14585672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.